WHO releases updated guidelines for TB diagnosis, recommending rapid molecular tests as initial tests for TB detection.

18 June 2020, Geneva | Nucleic acid amplification tests (NAAT) are promising technologies for the rapid and accurate detection of TB and resistance to selected anti-TB agents. In December 2020, the World Health Organization (WHO) will convene a Guidelines Development Group (GDG) meeting to update its diagnostic guidelines on the use of NAATs to detect TB and resistance to selected anti-TB agents. Ahead of this meeting, WHO will commission reviews of relevant evidence on diagnostic accuracy for several NAAT assays.

The World Health Organization (WHO) is convening a Guideline Development Group (GDG) to advise on updates needed to its recommendations on the systematic screening for tuberculosis (TB).

WHO releases updated guidelines for the treatment of drug-resistant TB.

05 June 2020 | Geneva - The World Health Organization (WHO) Global TB Programme is pleased to share a compendium of key resources to facilitate knowledge sharing and promote research on the interlinkages between tuberculosis (TB) and COVID-19. Given similar disease presentation between TB and COVID-19, and the adverse impact of this pandemic on TB services and health outcomes, knowledge sharing is important for a timely response to the dual threat of COVID-19 and TB.

New guidance from the World Health Organization (WHO) will help countries keep essential health services running whilst taking measures to keep people safe in the COVID-19 pandemic. Most health systems are facing challenges of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Countries must find ways to keep people safe and ensure the delivery of services such as emergency care for conditions like heart attacks and injury; immunization to prevent outbreaks; treatment for infectious diseases like HIV, malaria and tuberculosis; and screening and treatment for noncommunicable diseases like cancer and diabetes.           

The 73rd World Health Assembly adopts a resolution to bring the world together to fight the COVID-19 pandemic.

COVID-19-related service disruptions could cause hundreds of thousands of extra deaths from AIDS-related illnesses, including from TB.

The World Health Organization Global TB Program is collating information on ongoing research projects at the interface of TB and COVID-19, with a view to support collaboration among researchers, as well as with policy makers.

Call for expressions of interest from the World Health Organization (WHO) Region of the Americas with an extended deadline until 3 May 2020. The aim of the Task Force is to intensify the voice of civil society in ending TB at all levels.